Organogenesis Share Price

Organogenesis Share Price

NASDAQ: ORGO | Micro Cap | Healthcare
$0.78
-$0.01 (-1.69%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Organogenesis Stock Performance

Open
$0.78
Prev. Close
$0.79
Circuit Range
N/A
Day Range
$0.76 - $0.81
Year Range
$0.73 - $5.90
Volume
11,397
Average Traded
$0.78

Organogenesis Share Price Today

As of 21 November 2026, Organogenesis Holdings Inc. Class A's share price is $0.78. The stock opened at $0.78, compared to its previous close of $0.79. During today's trading session, Organogenesis Holdings Inc. Class A's share price traded between $0.76 and $0.81, with an average price of $0.78. Over the past 52 weeks, the stock has recorded a high of $5.90 and a low of $0.73. In terms of performance, Organogenesis Holdings Inc. Class A's share price has declined by 69.77% over the last six months and is down 84.97% on a year-on-year basis.

Organogenesis Share Price Chart

Line chart of the Organogenesis price trend over the selected period. The price fell overall, ranging from 0.75 to 0.81, ending at 0.78.
$0.76$0.81
L
Show Current Price
H

Organogenesis Stock Fundamentals & Key Indicators

Market Cap
$98.84M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.16
Revenue (TTM)
$564.17B
Return On Equity (TTM)
-125.39%
Profit Margin
3.55%
Debt to Equity
0.09
Quarterly Earnings Growth YoY
-193.31%

Organogenesis Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$225.61$37.23$43.76$45.46
Net Profit$35.12-$53.16-$99.34-$32.77
Net Profit Margin15.57%-142.79%-227.01%-72.09%
Income ChangeN/A-251.37%-86.87%67.01%

Organogenesis Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$450.89$433.14$482.04$564.17
Net Profit$15.53$4.95-$0.94$20.02
Net Profit Margin3.44%1.14%-0.20%3.55%
Income ChangeN/A-68.13%-118.99%2229.79%

Organogenesis Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets236.54211.95234.98226.75
Current Assets362.19285.94225.04222.61
Total Assets598.73497.89460.03449.36
Non Current Liabilities64.6935.09100.85108.67
Current Liabilities100.1277.4880.5175.02
Total Liabilities164.81112.57181.36183.69
Shareholders' Equity433.92262.9278.66265.67

Organogenesis Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-10.3114.2130.9224.86
Investing-14.15-10.03-24.36-33.9
Financing-17.3627.64-5.51-2.2

About Organogenesis

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Organogenesis Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.79
$0.78
+2.35%
Oct 2026
$1.37
$0.77
-44.57%
Sep 2026
$1.70
$1.38
-20.69%
Aug 2026
$2.42
$1.74
-26.74%
Jul 2026
$2.44
$2.38
-1.86%
Jun 2026
$2.56
$2.42
-6.20%
May 2026
$2.33
$2.58
+9.79%
Apr 2026
$2.40
$2.35
-1.26%
Mar 2026
$3.10
$2.38
-25.39%
Feb 2026
$4.11
$3.19
-20.45%
Jan 2026
$5.16
$4.01
-22.59%
Dec 2025
$5.15
$5.18
-0.19%

Organogenesis Share Price FAQs